HomeCompanies › SYRE

Spyre Therapeutics

Most recent annual filing: 2026-04-15

Catalyst timeline

7 trackedQuarter catalyst calendar →
  1. Spyre pipeline POC readout2026Spyre pipeline POC readout, 2026, major
  2. SPY072 SKYWAY Ph2 readoutSep 2026SPY072 SKYWAY Ph2 readout, Sep 2026, major
  3. SPY003 Ph1 interimSep 2026SPY003 Ph1 interim, Sep 2026, notable
  4. SKYWAY RA sub-study filingSep 2026SKYWAY RA sub-study filing, Sep 2026, notable
  5. SKYWAY PsA and axSpA sub-studies4Q 2026SKYWAY PsA and axSpA sub-studies, 4Q 2026, routine
  6. SPY120/SPY130/SPY230 combinations + all monotherapies2027SPY120/SPY130/SPY230 combinations + all monotherapies, 2027, routine
  7. SKYLINE Part B induction corporate2027SKYLINE Part B induction corporate, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (13 active programs)

Biotech Distilled coverage (11)

Articles open on Substack. Some deep dives are subscriber-only.